STAT3 and astrogliogenesis in HIV-1 associated dementia
HIV-1 相关痴呆中的 STAT3 和星形胶质细胞生成
基本信息
- 批准号:7939642
- 负责人:
- 金额:$ 18.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-28 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS Dementia ComplexAdenovirus VectorAdultAffectAlzheimer&aposs DiseaseAstrocytesBasal GangliaBrainCell Culture SystemCell Culture TechniquesCell Differentiation processCentral Nervous System InfectionsConfocal MicroscopyCritical PathwaysDataDementiaDominant-Negative MutationEncephalitisFigs - dietaryFlow CytometryFunctional RNAGene ExpressionGlial Fibrillary Acidic ProteinHIVHIV-1HarvestHippocampus (Brain)HumanImmuneIn VitroInfectionInflammationInflammatoryInjection of therapeutic agentJanus kinaseKnock-outLabelLengthLifeLipopolysaccharidesMediatingMicrogliaModelingMolecular ProfilingMonitorMononuclearMultiple SclerosisMusNervous system structureNeural PathwaysNeuraxisNeurodegenerative DisordersNeuronal DifferentiationNeuronsNorthern BlottingNucleotidesOligodendrogliaParahippocampal GyrusParkinson DiseasePathogenesisPathway interactionsPatientsPhagocytesPlayProcessReactionRegulator GenesResearchReverse Transcriptase Polymerase Chain ReactionRoleSTAT proteinSTAT3 geneSignal PathwaySignal TransductionSmall Interfering RNAStaining methodStainsStat3 proteinStem cellsSystemTNF geneTestingTherapeutic InterventionTherapeutic StudiesTimeTranscriptTranslational RepressionTubulinWestern BlottingWorkadult neurogenesisbasebrain tissuecytokinedentate gyrusdesignembryonic stem cellfludarabinegliogenesisimmune activationimmunocytochemistryin vivoinhibitor/antagonistinjuredlocked nucleic acidmRNA Transcript Degradationmacrophagemigrationmouse modelnerve stem cellnestin proteinneurogenesisnovelpublic health relevancerelating to nervous systemresponsestemstem cell therapytyrphostin AG-490
项目摘要
DESCRIPTION (provided by applicant): Active neurogenesis occurs throughout life and relies upon the proliferation, migration and proper differentiation of neural stem/progenitor cells (NPCs). Diminished adult neurogenesis is considered a potential factor in the pathogenesis of HIV-1-associated dementia (HAD). In HAD, HIV-1-infected and immune-activated brain mononuclear phagocytes (MP; perivascular macrophages and microglia) drive central nervous system (CNS) inflammation and may alter normal neurogenesis. We previously demonstrated HIV-1-infected and activated MP inhibit neurogenesis, while enhancing astrogliogenesis in vitro and in vivo, through secretion of inflammatory cytokines such as IL-1b and TNF-a. Our preliminary study showed both IL-1b and TNF-a, as well as HIV-1-infected and LPS-activated MP induced STAT3 activation, a critical pathway of astrogliogenesis. Furthmore, microRNA-9 (miR-9) and brain-specific microRNA-124 (miR-124), factors shown to inhibit STAT3 activation, promote neuronal differentiation and inhibit astrocyte differentiation, are decreased in response to cytokine (IL-1b and TNF-a) treatment. Based on these observations, we hypothesize that HIV-1-infected and immune-activated MP promote NPC astrogliogenesis through secreted factors including cytokines (IL-1b and TNF-a) via the STAT3 pathway, and that miR-9 and miR-124 regulate this process through modulation of STAT3 activation. In this proposal, we will study the STAT3 pathway in NPCs following stimulation with inflammatory cytokines (including IL-1b and TNF-a) and HIV-1-infected and immune-activated MP and examine the effect on astrogliogenesis. We will also investigate the role of miRNAs (miR-9 and miR-124) in STAT3 activation and the modulation of human NPC differentiation mediated by cytokines (IL-1b and TNF-a) and HIV-1-infected and activated MP. We will test this hypothesis using a primary human NPC culture system and a severe combined immune deficient (SCID) HIV-1 encephalitis (HIVE) mouse model. This research will generate important data deciphering the role of brain inflammation in neurogenesis during progressive HIV-1 infection of the CNS. In addition, the work will also identify potential targets for therapeutic intervention for neural stem cell therapy.
PUBLIC HEALTH RELEVANCE: Diminished adult neurogenesis is considered a potential factor in the pathogenesis of HIV-1-associated dementia, in which HIV-1-infected and immune-activated macrophages drive central nervous system (CNS) inflammation. The study of the factors produced by these inflammatory cells and the signaling pathways involved in neural stem/progenitor cell differentiation will generate important data deciphering the role of brain inflammation in neurogenesis during progressive HIV-1 infection of the CNS, and identify potential targets for therapeutic intervention for neural stem cell therapy.
描述(由申请人提供):活跃的神经发生发生在整个生命过程中,并且依赖于神经干/祖细胞(NPC)的增殖、迁移和适当分化。成人神经发生减少被认为是 HIV-1 相关痴呆 (HAD) 发病机制的潜在因素。在 HAD 中,HIV-1 感染和免疫激活的大脑单核吞噬细胞(MP;血管周围巨噬细胞和小胶质细胞)会导致中枢神经系统 (CNS) 炎症,并可能改变正常的神经发生。我们之前证明,HIV-1感染并激活的MP可抑制神经发生,同时通过分泌IL-1b和TNF-a等炎性细胞因子,在体外和体内增强星形胶质细胞生成。我们的初步研究表明 IL-1b 和 TNF-a 以及 HIV-1 感染和 LPS 激活的 MP 诱导 STAT3 激活,这是星形胶质细胞生成的关键途径。此外,microRNA-9 (miR-9) 和大脑特异性 microRNA-124 (miR-124) 是抑制 STAT3 激活、促进神经元分化和抑制星形胶质细胞分化的因子,在细胞因子(IL-1b 和 TNF-a)治疗后会减少。基于这些观察结果,我们假设 HIV-1 感染和免疫激活的 MP 通过 STAT3 途径通过包括细胞因子(IL-1b 和 TNF-a)在内的分泌因子促进 NPC 星形胶质细胞生成,并且 miR-9 和 miR-124 通过调节 STAT3 激活来调节这一过程。在本提案中,我们将研究炎症细胞因子(包括 IL-1b 和 TNF-a)以及 HIV-1 感染和免疫激活 MP 刺激后 NPC 中的 STAT3 通路,并检查其对星形胶质细胞生成的影响。我们还将研究 miRNA(miR-9 和 miR-124)在 STAT3 激活以及细胞因子(IL-1b 和 TNF-a)以及 HIV-1 感染和激活的 MP 介导的人类 NPC 分化调节中的作用。我们将使用原代人类 NPC 培养系统和严重联合免疫缺陷 (SCID) HIV-1 脑炎 (HIVE) 小鼠模型来检验这一假设。这项研究将产生重要数据,以破译大脑炎症在中枢神经系统进行性 HIV-1 感染过程中神经发生中的作用。此外,这项工作还将确定神经干细胞治疗干预的潜在靶点。
公共卫生相关性:成人神经发生减少被认为是 HIV-1 相关痴呆发病机制的潜在因素,其中 HIV-1 感染和免疫激活的巨噬细胞会导致中枢神经系统 (CNS) 炎症。对这些炎症细胞产生的因子以及参与神经干/祖细胞分化的信号通路的研究将产生重要的数据,以破译中枢神经系统进行性HIV-1感染期间脑炎症在神经发生中的作用,并确定神经干细胞治疗干预的潜在靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hui Peng其他文献
Hui Peng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hui Peng', 18)}}的其他基金
microRNA-124 restores nerurogenesis in HIV-1 associated neurocognitve disorders
microRNA-124 恢复 HIV-1 相关神经认知障碍的神经发生
- 批准号:
8877662 - 财政年份:2014
- 资助金额:
$ 18.38万 - 项目类别:
microRNA-124 restores nerurogenesis in HIV-1 associated neurocognitve disorders
microRNA-124 恢复 HIV-1 相关神经认知障碍的神经发生
- 批准号:
9036544 - 财政年份:2014
- 资助金额:
$ 18.38万 - 项目类别:
相似海外基金
Clinical application of boron-conjugated adenovirus vector for neutron capture therapy
硼缀合腺病毒载体中子捕获治疗的临床应用
- 批准号:
19K09482 - 财政年份:2019
- 资助金额:
$ 18.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Vascular-targeted gene therapy to block proliferation of smooth muscle cells using a novel adenovirus vector
使用新型腺病毒载体进行血管靶向基因治疗以阻止平滑肌细胞增殖
- 批准号:
2273599 - 财政年份:2019
- 资助金额:
$ 18.38万 - 项目类别:
Studentship
Gene therapy for diabetes mellitus based on the suppression of lipotoxicity using an improved adenovirus vector
使用改进的腺病毒载体抑制脂毒性的糖尿病基因治疗
- 批准号:
18K14964 - 财政年份:2018
- 资助金额:
$ 18.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanisms of induction of mucosal immunity by adenovirus vector vaccine
腺病毒载体疫苗诱导粘膜免疫的机制
- 批准号:
16K18873 - 财政年份:2016
- 资助金额:
$ 18.38万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Hemophilia B Gene Therapy via CRISPR/Cas9-Targeted Integration of the Factor IX Gene using Adenovirus Vector Delivery
使用腺病毒载体递送通过 CRISPR/Cas9 靶向整合因子 IX 基因进行 B 型血友病基因治疗
- 批准号:
9193681 - 财政年份:2016
- 资助金额:
$ 18.38万 - 项目类别:
Gene therapy for diabetes mellitus and gene function analysis using a novel adenovirus vector
使用新型腺病毒载体进行糖尿病基因治疗和基因功能分析
- 批准号:
15K18939 - 财政年份:2015
- 资助金额:
$ 18.38万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Innate immue response through glycolipids by adenovirus-vector
腺病毒载体通过糖脂产生先天免疫反应
- 批准号:
26450450 - 财政年份:2014
- 资助金额:
$ 18.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of targeting adenovirus vector as boron carrier for boron neutron capture therapy
开发靶向腺病毒载体作为硼中子捕获疗法的硼载体
- 批准号:
26462183 - 财政年份:2014
- 资助金额:
$ 18.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a novel method for highly efficient gene targeting by adenovirus vector on human naive pluripotent stem cells
开发一种通过腺病毒载体高效基因靶向人类幼稚多能干细胞的新方法
- 批准号:
26893253 - 财政年份:2014
- 资助金额:
$ 18.38万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Development of adenovirus vector lacking VA RNA genes for efficient microRNA expression
开发缺乏 VA RNA 基因的腺病毒载体以实现有效的 microRNA 表达
- 批准号:
24701021 - 财政年份:2012
- 资助金额:
$ 18.38万 - 项目类别:
Grant-in-Aid for Young Scientists (B)